Medindia

X

Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.

Tuesday, December 16, 2008 General News J E 4
Advertisement
SAN DIEGO, Dec. 16 Accumetrics, Inc. has appointed 20-year industry veteran Ad de Waard as Vice President of International Sales and Marketing.



"Ad joins us at an important juncture in the evolution of Accumetrics, as we are now well-positioned to expand our international business," says Timothy I. Still, President and CEO at Accumetrics. "His extensive experience in managing global distribution networks will be invaluable as we continue on our growth path and expand our capabilities to provide Accumetrics' products to customers worldwide."



Mr. de Waard has more than 20 years' experience in the in-vitro diagnostics industry in roles of increasing responsibility involving international sales and marketing and general management. He has launched several new cardiovascular products, including products in the area of platelet function analysis.



Prior to Accumetrics, Mr. de Waard served as Director of International Business Development at Inverness, Inc., which acquired HemoSense, Inc. in 2007. Prior to his time at HemoSense, he held various international marketing positions, including those at Dade Behring and Amersham International. In his new position at Accumetrics, Mr. de Waard will be based in the Netherlands.



Mr. de Waard holds several degrees and certificates, including his HBO (the Dutch equivalent of a bachelor degree) from the School of Clinical Chemistry, The Netherlands, MBO certificates in process chemistry and electrotechnology, and completion of the marketing program at the Netherlands Institute of Marketing.



About Accumetrics (www.accumetrics.com)

Accumetrics is committed to advancing medical understanding of platelet function and enhancing quality of care for patients receiving antiplatelet therapies by providing industry-leading and widely accessible diagnostic tests for rapid platelet function assessment.



Accumetrics' VerifyNow(R) System is the first rapid and easy to use platform for measuring an individual's response to multiple antiplatelet agents. Addressing every major antiplatelet drug, including FDA-cleared products for aspirin, Plavix(R), ReoPro(R), and Integrilin(R), the VerifyNow System provides a valuable tool to help physicians make informed treatment decisions.



The Accumetrics logo and VerifyNow are registered trademarks of Accumetrics, Inc. ReoPro is a registered trademark of Centocor, Inc. Integrilin is a registered trademark of Millennium Pharmaceuticals. Plavix is a registered trademark of Sanofi-Aventis.





CONTACT: Jules Abraham Lippert Heilshorn & Associates 212-838-3777 jabraham@lhai.com Timothy I. Still Accumetrics press@accumetrics.com

SOURCE Accumetrics, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Usher Teams With Body By Milk to Give Teens Once-i...
S
U.S. Preventive Medicine Praises Selection of Tom ...